Sponsor or institution
Clinical trials and research at Krystal Biotech, Inc.
As of November 12, 2026, Find a Trial lists 9 clinical trials run by Krystal Biotech, Inc. that are recruiting, in United States. By phase: Phase 1/2 (3), Phase 1 (2), Phase 3 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Topical KB111 for Hailey-Hailey Disease (early phase, kids and adults) | Early Phase 1 | Miami, Florida | Recruiting | Jul 21, 2026 |
| KB803 eye drops versus placebo for people with dystrophic epidermolysis bullosa | Phase 3 | Rancho Santa Margarita, California and 4 other locations | Recruiting | Jun 12, 2025 |
| KB801 versus placebo for healing corneal defects in stage 2 or 3 neurotrophic keratitis | Phase 1/2 | Irvine, California and 8 other locations | Recruiting | May 31, 2025 |
| Observing corneal abrasions in patients with Dystrophic Epidermolysis Bullosa | — | Pittsburgh, Pennsylvania | Recruiting | Aug 20, 2024 |
| Treatment of advanced lung cancer using KB707 | Phase 1/2 | Dothan, Alabama and 13 other locations | Recruiting | Jan 29, 2024 |
| Treatment of Alpha-1 Antitrypsin Deficiency with KB408 | Phase 1 | Gainesville, Florida and 2 other locations | Recruiting | Sep 21, 2023 |
| Assessing KB707 for treating advanced melanoma and solid tumors | Phase 1/2 | Los Angeles, California and 14 other locations | Recruiting | Aug 1, 2023 |
| Assessing KB407 for treating cystic fibrosis | Phase 1 | Gainesville, Florida and 5 other locations | Recruiting | Aug 17, 2022 |
| Long-term follow-up for gene therapy in skin conditions | — | Rancho Santa Margarita, California and 2 other locations | Recruiting | Jun 8, 2021 |
All recruiting trials (9)
-
Topical KB111 for Hailey-Hailey Disease (early phase, kids and adults)
This study tests whether a topical KB111 treatment is safe and helps with lesions in people with Hailey-Hailey disease, including adolescents and adults.
-
KB803 eye drops versus placebo for people with dystrophic epidermolysis bullosa
This trial tests whether KB803 eye drops, given three times a week, can reduce recurrent corneal abrasions in children and adults with dystrophic epidermolysis bullosa.
-
KB801 versus placebo for healing corneal defects in stage 2 or 3 neurotrophic keratitis
This tests whether KB801 eye drops can safely heal persistent corneal epithelial defects in adults with stage 2 or 3 neurotrophic keratitis.
-
Observing corneal abrasions in patients with Dystrophic Epidermolysis Bullosa
This study looks at how corneal abrasions develop over time in people with Dystrophic Epidermolysis Bullosa by tracking their symptoms through weekly diaries and monthly questionnaires.
-
Treatment of advanced lung cancer using KB707
This study is testing a new treatment called KB707 to see if it can help adults with advanced lung cancer by boosting their immune response, especially for those who haven't had success with standard therapies.
-
Treatment of Alpha-1 Antitrypsin Deficiency with KB408
This study is testing a new treatment called KB408 to see if it can help adults with alpha-1 antitrypsin deficiency breathe better by delivering a key protein directly to their lungs.
-
Assessing KB707 for treating advanced melanoma and solid tumors
This study is testing a new treatment called KB707, which is a modified virus, to see if it can help adults with advanced melanoma and other solid tumors who haven't had success with regular treatments.
-
Assessing KB407 for treating cystic fibrosis
This study is testing a new inhaled treatment called KB407 to see if it is safe and how well it works for adults with cystic fibrosis.
-
Long-term follow-up for gene therapy in skin conditions
This study is checking the long-term safety of a gene therapy for people with a skin condition called dystrophic epidermolysis bullosa who have already received the treatment.
Quick answers
How many clinical trials run by Krystal Biotech, Inc. are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 3, Phase 1: 2, Phase 3: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.